Recent studies suggest that azelaic acid exerts its anti-inflammatory effect through binding to cyclooxygenase enzymes and its anticancer activity by targeting pirin, an iron-containing nuclear protein and transcription cofactor highly expressed in tumor cells [38,43], which is involved in the regulation of the NF-kB pathway [44]. Here, NFKB1 is linked to neoplasm.